1Bioshop JF, Matthews JP, Young GA, et al. intensified induction chemotherapy with high dose cytarabine and etopusidc for acute myeioid leukemia: a review and update results of the Australian Leukemia Study Group. Leuk Lymphoma , 1998, 28:315-327.
2Weick JK, Kopecky K J, Appelbaum FR, et al. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubiein in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group Study. Blood, 1996, 88:2841-2851.
3Mitus AJ, Miller KB, Schenkein DP, et al. huproved survival for patients with acute myelogenous leukemia. J Clin Oncol, 1995, 13:560-569.
4Mantovani L, Hasenelever D,Krahl R,et al. Intermediate-dose cvtarabine treatment delivered at moderate infusion rates for de novo acutemyeloitt leukemia-resuhs of a phase I -II study. Leuk Lymphoma,2002, 43:265-274.
5Bioshop JF, Matthews JP, Young GA, et al. A randomized study of high-dose cytarabine in induction in acute mveloid leukemia. Blood,1996, 87:1710-1717.
10Beksac M,Akat H,Koc H,et al.P-glycoprotein expression inrefractory hematologyical neoplasms and circumvention of resis- tance with verapamil or cyclosporine A containing protocols[J]. Med Oncol Tumor Pharmacother, 1992,9(2) : 101-105.
